Management of pregnant inflammatory bowel disease patients during the covid-19 pandemic
Journal of Crohn's and Colitis , Volume 14 p. S807- S814
The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory bowel disease [IBD]. Care for pregnant IBD patients in itself is a complex issue because of the delicate balance between controlling maternal IBD as well as promoting the health of the unborn child. This often requires continued immunosuppressive maintenance medication or the introduction of new IBD medication during pregnancy. The current global COVID-19 pandemic creates an additional challenge in the management of pregnant IBD patients. In this paper we aimed to answer relevant questions that can be encountered in daily clinical practice when caring for pregnant women with IBD during the current COVID-19 pandemic.
|Pregnancy, inflammatory bowel disease, COVID-19, SARS-CoV2|
|Journal of Crohn's and Colitis|
|Organisation||Department of Gastroenterology & Hepatology|
de Lima-Karagiannis, A, Juillerat, P, Sebastian, S, Pedersen, N.L, Bar-Gil Shitrit, A., & van der Woude, C.J. (2020). Management of pregnant inflammatory bowel disease patients during the covid-19 pandemic. Journal of Crohn's and Colitis, 14, S807–S814. doi:10.1093/ecco-jcc/jjaa125